Corbus Pharma(CRBP.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Corbus Pharma
CRBP.US
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
1.820 T
CRBP.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    SBIO
    -1.24%
    US
    XBI
    -0.69%
    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    SBIO
    -1.24%
    US
    XBI
    -0.69%

    Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    LABU
    -2.35%
    US
    IBBQ
    +0.07%
    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    LABU
    -2.35%
    US
    IBBQ
    +0.07%

    Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

    Tip Ranks·
    US
    CRBP
    -8.04%
    US
    XBI
    -0.69%
    US
    IBBQ
    +0.07%
    Tip Ranks·
    US
    CRBP
    -8.04%
    US
    XBI
    -0.69%
    US
    IBBQ
    +0.07%

    Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    SBIO
    -1.24%
    US
    PBE
    +0.11%
    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    SBIO
    -1.24%
    US
    PBE
    +0.11%

    Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    BBH
    +0.68%
    US
    IBBQ
    +0.07%
    MarketWatch Automated·
    US
    CRBP
    -8.04%
    US
    BBH
    +0.68%
    US
    IBBQ
    +0.07%
    © 2026 Longbridge｜Disclaimer